References of "Julémont, F"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailThe use of nimesulide and its analogues in cancer chemoprevention
Renard, Jean-François ULg; Julémont, F.; De Leval, X. et al

in Anti-Cancer Agents in Medicinal Chemistry (2006), 6

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailStructure-based pharmacophore of COX-2 selective inhibitors and identification of original lead compounds from 3D database searching method
Michaux, C.; De Leval, X.; Julémont, F. et al

in European Journal of Medicinal Chemistry (2006), 41

Detailed reference viewed: 30 (0 ULg)
Full Text
Peer Reviewed
See detailA new potential cyclooxygenase-2 inhibitor, pyridinic analogue of nimesulide
Michaux, C.; Charlier, C.; Julémont, F. et al

in European Journal of Medicinal Chemistry (2005), 40

Detailed reference viewed: 2 (1 ULg)
Peer Reviewed
See detailPharmacophore generation to design new leads for selective cyclooxygenase-2 inhibition
Michaux, C.; Julemont, F.; De Leval, X. et al

Poster (2004, October 07)

Detailed reference viewed: 10 (0 ULg)
Peer Reviewed
See detailIdentification d’inhibiteurs sélectifs de la cyclooxygénase-2 (COX-2)
Michaux, C.; Julemont, F.; De Leval, X. et al

Conference (2004, June)

Detailed reference viewed: 13 (0 ULg)
Peer Reviewed
See detailIdentification d’un inhibiteur COX-2 sélectif », 18èmes Journées Franco-belges de Pharmacochimie
Michaux, C.; Julemont, F.; De Leval, X. et al

Poster (2004, June)

Detailed reference viewed: 6 (0 ULg)
Peer Reviewed
See detailSynthèse et évaluation pharmacologique d’analogues pyridiniques du nimésulide : variation du pont « inter-cycle
Julemont, F.; De Leval, X.; Dogne, J. M. et al

Poster (2004, June)

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailFirst and second generations of COX-2 selective inhibitors
De leval, X.; Julémont, F.; Benoit, V. et al

in Mini Reviews in Medicinal Chemistry (2004), 4

Detailed reference viewed: 25 (4 ULg)
Full Text
Peer Reviewed
See detailDesign, synthesis and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors
Julémont, F.; de Leval, X.; Michaux, C. et al

in Journal of Medicinal Chemistry (2004), 47

Detailed reference viewed: 15 (2 ULg)
Full Text
Peer Reviewed
See detailIdentification of COX-2 selective inhibitor
Michaux, C.; Julémont, F.; de Leval, X. et al

in Fundamental & Clinical Pharmacology (2004)

Detailed reference viewed: 7 (1 ULg)
Full Text
Peer Reviewed
See detailRecent development in the field of dual COX / 5-LOX inhibitors
Julémont, F.; Dogné, J.-M.; Pirotte, Bernard ULg et al

in Mini Reviews in Medicinal Chemistry (2004), 4

Detailed reference viewed: 9 (1 ULg)
Peer Reviewed
See detailSynthèse et évaluation pharmacologique de N-pyridinyl-alkanesulfonamides apparentés au nimésulide
Julemont, F.; De Leval, X.; Michaux, C. et al

Poster (2003, May)

Detailed reference viewed: 4 (0 ULg)
Peer Reviewed
See detailPyridinic sulfonamides as potential COX-2 inhibitors
Julemont, F.; De Leval, X.; Damas, J. et al

Poster (2003, May)

Detailed reference viewed: 7 (0 ULg)
Peer Reviewed
See detailPharmacophore generation to design new leads for selective cyclooxygenase-2 (COX-2) inhibition
Michaux, C.; De Leval, X.; Julemont, F. et al

Poster (2003, May)

Detailed reference viewed: 10 (0 ULg)
See detailPyridinic sulfonamide derivatives, method of production and use thereof
Delarge, J.; Pirotte, Bernard ULg; Dogné, J. M. et al

Patent (2003)

Detailed reference viewed: 5 (2 ULg)
Full Text
Peer Reviewed
See detailRecent developments in 5-lipoxygenase inhibitors
Julémont, F.; Dogné, J.-M.; Laeckmann, D. et al

in Expert Opinion on Therapeutic Patents (2003), 13

Detailed reference viewed: 7 (2 ULg)
Full Text
Peer Reviewed
See detailPharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation
De Leval, X.; Benoit, V.; Delarge, J. et al

in Prostaglandins, Leukotrienes, and Essential Fatty Acids (2003)

Detailed reference viewed: 12 (3 ULg)
Peer Reviewed
See detailRationalization of the binding mode of pyridinic compounds derived from nimesulide, a preferential cyclooxygenase-2 inhibitor
Michaux, C.; Charlier, C.; Julemont, F. et al

Poster (2002, November 15)

Detailed reference viewed: 3 (0 ULg)
Peer Reviewed
See detailRationalization of the binding mode of pyridinic compounds derived from nimesulide, a preferential cyclooxygenase-2 inhibitor
Michaux, C.; Charlier, C.; Julemont, F. et al

Poster (2002, September 26)

Detailed reference viewed: 1 (0 ULg)
Peer Reviewed
See detailEvaluation of pyridinic sulfonamides related to nimesulide as COX-2 selective inhibitors
Julemont, F.; De Leval, X.; Neven, P. et al

Poster (2002, March 02)

Detailed reference viewed: 4 (0 ULg)